Page last updated: 2024-12-05

methyl octanoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Methyl octanoate, also known as methyl caprylate, is a colorless liquid with a fruity, coconut-like odor. It is a naturally occurring compound found in various fruits and essential oils. Its synthesis typically involves the esterification of octanoic acid with methanol. Methyl octanoate has been investigated for its potential applications in various fields, including flavoring, fragrances, and pharmaceuticals. Its pleasant aroma makes it a valuable ingredient in cosmetics and food additives. In terms of its effects, methyl octanoate is generally considered safe for human consumption, but further research is needed to assess its potential long-term effects. Additionally, its antimicrobial properties have been explored for its possible applications in food preservation. Methyl octanoate is studied due to its versatile nature, its potential as a sustainable alternative to synthetic compounds, and its intriguing biological properties. '

methyl octanoate : A fatty acid methyl ester resulting from the formal condensation of the carboxy group of octanoic acid with the hydroxy group of methanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8091
CHEMBL ID3183908
CHEBI ID87432
SCHEMBL ID27416
MeSH IDM0117391

Synonyms (75)

Synonym
methyl caprylate
octanoic acid methyl ester
nsc3710
nsc-3710
111-11-5
methyl octanoate
octanoic acid, methyl ester
caprylic acid methyl ester
uniphat a20
methyl n-octanoate
brn 1752270
methyl octylate
einecs 203-835-0
fema no. 2728
hsdb 5544
nsc 3710
ai3-01979
methyl caprylate (natural)
methyl octanoate, 99%, fg
methyl octanoate, 99%
NCGC00163978-01
octanoic acid methyl ester (fame mix)
1A56EE3E-501F-4327-A796-0B21C0CBD8BF
n-octanoic acid methyl ester
S0306
O0033
A802294
NCGC00163978-03
NCGC00163978-02
AKOS005721017
we(1:0/8:0)
LMFA07010446
dtxcid606864
cas-111-11-5
NCGC00259021-01
NCGC00254484-01
tox21_201470
tox21_300557
dtxsid2026864 ,
BBL011470
STL146582
7mo740x6ql ,
ec 203-835-0
4-02-00-00986 (beilstein handbook reference)
unii-7mo740x6ql
FT-0628328
methyl caprylate [inci]
octanoic acid, methyl ester [hsdb]
methyl caprylate [usp-rs]
methyl octanoate [fhfi]
SCHEMBL27416
methyl ester of octanoic acid
n-caprylic acid methyl ester
caprylic acid, methyl ester
chebi:87432 ,
CHEMBL3183908
mfcd00009551
J-002523
J-803002
2-bromo-2-ethylbutanoyl chloride
J-519982
methyl ester octanoic acid
methyl caprylate, united states pharmacopeia (usp) reference standard
methyl octanoate, certified reference material, tracecert(r)
methyl octanoate, analytical standard
octanoic acid-methyl ester
methyl caprylate; octanoic acid methyl ester; methyl octanoate
c08 fame
Q3348789
2-benzofurancarboxylicacid,6-nitro-
CS-0128781
AS-56805
HY-W087943
methyloctanoate
EN300-7110910
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
fatty acid methyl esterA fatty acid ester that is the carboxylic ester obtained by the formal condensation of a fatty acid with methanol.
octanoate esterAny fatty acid ester in which the carboxylic acid component is octanoic acid (caprylic acid).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen nuclear receptor alphaHomo sapiens (human)Potency27.30600.000229.305416,493.5996AID743079
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1659751Agonist activity at TRPA1 (unknown origin) at 1000 uM relative to AITC2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Identification of a new class of non-electrophilic TRPA1 agonists by a structure-based virtual screening approach.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (22.22)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's4 (44.44)24.3611
2020's2 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.57 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index57.05 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]